Work

Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)

Year: 2019

Type: article

Study design: Observational Study

Source: The American Journal of Cardiology

DOI: 10.1016/j.amjcard.2019.09.020

Authors: Erika M. Giblin, Kirkwood F. Adams, Larry Hill, Gregg C. Fonarow, Fredonia B. Williams, Puza P. Sharma, Nancy M. Albert, Javed Butler, Adam D. DeVore, Carol I. Duffy, Adrian F. Hernandez, Kevin McCague, John A. Spertus, Laine Thomas, J. Herbert Patterson

Institutions: Campbell University, Vidant Medical Center, University of North Carolina at Chapel Hill, Duke University, Duke Medical Center, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Cleveland Clinic, University of Mississippi Medical Center

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

Funders: Boehringer Ingelheim, Abbott Laboratories, Amgen, Bristol-Myers Squibb, AstraZeneca, Merck, Novartis, Sanofi, Medtronic, Patient-Centered Outcomes Research Institute, Bayer Fund, European Commission, Novo Nordisk, National Institutes of Health, National Institute of General Medical Sciences, Janssen Pharmaceuticals

Awards: G1422855837, Mississippi Center for Clinical and Translational Research

OpenAlex ID: W2976185156

FWCI: 2.28

Cites: 12

Cited by: 25

Related to: 10